Accuracy of Blood Glucose Detection by Diabetes Alert Dogs
Status unconfirmed
Conditions studied: Type I Diabetes Mellitus
In brief
Even though there is growing interest in and use of trained Diabetes Alert Dogs (DADs) as a way to monitor blood glucose in type 1 diabetes (T1D), no scientific studies have confirmed the ability of DADs to accurately detect extreme high and low blood sugar. The current project is the first preliminary investigation into the accuracy of DADs, using scientifically rigorous research methods similar to those required to demonstrate accuracy in blood glucose meters. The primary aim of the project is to test the hypotheses that DADs are accurate at detecting extreme blood sugar levels in adults and children with T1D. The proposed project has several other secondary aims, which include determining: 1) the glycemic thresholds and time course for hypo- and hyperglycemic DAD alerts, 2) the degree to which alert accuracy is consistent across different DADs, and 3) whether or not DAD owners appear to experience better psychosocial status and quality of life compared to other individuals with T1D.
Key facts
- Study ID
- NCT02126605
- Run by
- University of Virginia
- People needed
- 16
- Starts
- 2014-07-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2014-04-30
Who can join
Age: 6 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The participant must have had type 1 diabetes for at least 1 year and been taking insulin since diagnosis
- The participant must have a DAD placed in their home for a minimum of 6 months.
- Participants must not currently be using a continuous glucose monitor (CGM) in their diabetes management.
- Participants must be capable of performing all tasks involved in the study protocol, including filling out questionnaires and diaries in English.
- Participants must have an internet-connected computer compatible with study software.
- Willingness to avoid consumption of acetaminophen-containing products for the duration of the study.
You may not qualify if…
- Pregnant women-self reported
- Current use of a CGM
- History of a systemic deep tissue infection with methicillin-resistant staph aureus or Candida albicans
Where it is running
- University of Virginia Center for Behavioral Medicine Research — Charlottesville, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.